Quick Takeaways
- Richard Brudnick has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $545,233.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Richard Brudnick
- Location
- Waltham, MA
- Summary
- The estimated net worth of Richard Brudnick is at least $545,233 dollars as of 18 Mar 2026. Richard Brudnick is the Director of Scholar Rock Holding Corp and owns shares of Scholar Rock Holding Corp (SRRK) stock worth about $451.8K. Richard Brudnick is the Director of InflaRx N.V. and owns shares of InflaRx N.V. (IFRX) stock worth about $46.5K. Richard Brudnick is the Chief Business Officer of Prime Medicine, Inc. and owns shares of Prime Medicine, Inc. (PRME) stock worth about $23.8K. Richard Brudnick is the Director of VOLITIONRX LTD and owns shares of VOLITIONRX LTD (VNRX) stock worth about $23.2K.
- Signature
- /s/ Christian Schmid, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Richard Brudnick and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Scholar Rock Holding Corp ($451,756).
- Past-year value change for that position: -$180,531.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Richard Brudnick
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | Director | $451,756 | -$180,531 | -29% | 29 May 2025 |
| IFRX | InflaRx N.V. | Director | $46,500 | 18 Mar 2026 | ||
| PRME | Prime Medicine, Inc. | Chief Business Officer | $23,790 | +$23,790 | +100% | 20 May 2025 |
| VNRX | VOLITIONRX LTD | Director | $23,187 | 12 Jan 2023 | ||
| CDAKQ | Codiak BioSciences, Inc. | Officer title: Chief Business Officer and Head of Corporate Strategy | 16 Feb 2022 |
Insider Transactions Reported by Richard Brudnick:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.